Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-17 Sale | 2022-05-19 07:31 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 130,000 | $8.2159 | $1,068,067 | 1,387 (Direct) | View |
| 2022-03-04 Sale | 2022-03-08 4:07 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 33,579 | $7.4517 | $250,219 | 357,036 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 07:47 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 7,590 | $8.1422 | $61,799 | 108,875 (Direct) | View |
| 2022-02-09 Sale | 2022-02-10 4:09 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 6,116 | $9.0602 | $55,412 | 102,905 (Direct) | View |
| 2021-08-10 Sale | 2021-08-12 4:04 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 50,860 | $9.9493 | $506,021 | 41,412 (Direct) | View |
| 2021-05-11 Sale | 2021-05-13 07:45 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 19,066 | $10.22 | $194,830 | 92,272 (Direct) | View |
| 2021-03-04 Sale | 2021-03-08 4:07 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 9,515 | $10.57 | $100,536 | 206,322 (Direct) | View |
| 2021-03-02 Sale | 2021-03-04 4:03 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 50,000 | $10.82 | $540,890 | 64,064 (Direct) | View |
| 2021-03-01 Sale | 2021-03-02 4:05 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 10,912 | $10.83 | $118,186 | 179,112 (Direct) | View |
| 2021-02-16 Sale | 2021-02-17 4:07 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 2,098 | $11.12 | $23,336 | 103,294 (Direct) | View |
| 2021-02-09 Sale | 2021-02-11 4:05 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 29,496 | $12.69 | $374,437 | 154,042 (Direct) | View |
| 2020-03-17 Sale | 2020-03-19 07:33 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 514 | $7.1635 | $3,682 | 45,561 (Direct) | View |
| 2020-02-14 Sale | 2020-02-18 07:23 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 11,472 | $12.14 | $139,295 | 50,416 (Direct) | View |
| 2020-02-10 Sale | 2020-02-11 06:57 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 5,544 | $12.27 | $68,025 | 65,571 (Direct) | View |
| 2019-12-31 Sale | 2020-01-02 06:08 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 2,459 | $9.9212 | $24,396 | 22,754 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-04 Option Award | 2022-03-08 4:07 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 140,750 | $0 | 357,036 (Direct) | View |
| 2022-03-04 Exercise | 2022-03-08 4:07 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 94,157 | $0 | 357,036 (Direct) | View |
| 2022-02-28 Exercise | 2022-03-02 07:47 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 21,682 | $0 | 108,875 (Direct) | View |
| 2022-02-08 Option Award | 2022-02-10 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 51,488 | $0 | 102,905 (Direct) | View |
| 2022-02-09 Exercise | 2022-02-10 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 16,121 | $0 | 102,905 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 07:45 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 37,884 | $0 | 92,272 (Direct) | View |
| 2021-03-05 Option Award | 2021-03-08 4:07 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 95,057 | $0 | 206,322 (Direct) | View |
| 2021-03-04 Exercise | 2021-03-08 4:07 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 18,905 | $0 | 206,322 (Direct) | View |
| 2021-02-28 Exercise | 2021-03-02 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 21,682 | $0 | 179,112 (Direct) | View |
| 2021-02-14 Exercise | 2021-02-17 4:07 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 5,355 | $0 | 103,294 (Direct) | View |
| 2021-02-09 Option Award | 2021-02-11 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 105,736 | $0 | 154,042 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 16,120 | $0 | 154,042 (Direct) | View |
| 2020-03-17 Exercise | 2020-03-19 07:33 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 1,014 | $0 | 45,561 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 07:11 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 86,730 | $0 | 86,730 (Direct) | View |
| 2020-02-14 Exercise | 2020-02-18 07:23 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 23,203 | $0 | 50,416 (Direct) | View |
| 2020-02-11 Option Award | 2020-02-13 07:04 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 17,850 | $0 | 17,850 (Direct) | View |
| 2020-02-09 Exercise | 2020-02-11 06:57 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 16,120 | $0 | 65,571 (Direct) | View |
| 2019-12-31 Exercise | 2020-01-02 06:08 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D | 4,640 | $0 | 22,754 (Direct) | View |